bioRxivNeurosciencePreprint
Multiomic Evidence for a Unified Model of Alzheimer's Disease Etiology Linking Microglial Flux Capacity and Astrocyte-Neuron Metabolic Breakdown
Tom Paterson, Jennifer A. RohrsiD, Timothy J. HohmaniD, Mark E. MapstoneiD, Peter J. MeikleiD, Rima F Kaddurah-DaoukiD, Allan I. LeveyiD, Leroy HoodiD, Alzheimer’s Disease Neuroimaging Initiative, Cory C. FunkiD
Abstract
Age and APOE genotype are the strongest known risk factors for late-onset Alzheimers disease (AD), but the mechanisms linking them to neuronal loss remain incompletely defined. Using multiomic data from the Alzheimers Disease Neuroimaging Initiative (ADNI), we propose a unified hypothesis in which two interdependent failure modes--saturation of microglial lipid flux capacity and disruption of the astrocyte-neuron lactate shuttle (ANLS) due to excess astrocytic membrane cholesterol--drive disease progression upstream of amyloid and tau pathology. Stratifying participants by cognitive score quartiles, we find consistent associations linking impaired lipid clearance, metabolic stress, and genetic variants regulating cholesterol handling. These processes appear to reinforce each other, resulting in accelerating neurodegeneration. Our hypothesis reframes AD as a systems-level collapse in metabolic coordination, rather than a purely linear pathological cascade. These insights emerged during the development of digital twin models for personalized interventions, highlighting the power of systems approaches to reveal hidden drivers of neurodegeneration.
- organism: human
- assay: bulk RNA-seq
- research focus: gene regulatory network inference
- research focus: differential expression
- research focus: benchmarking
- research focus: database / resource
- approach: statistical model
- approach: simulation
- Citations
- 4
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Microglia-Dependent and Independent Modulation of Brain Lipid Metabolism in Alzheimer's Disease Revealed by Pharmacological and Genetic Microglial Depletion
Ziying Xu, Sepideh Kiani Shabestari, … Xianlin Han·bioRxiv·Nov 18, 2024
- Neuronal APOE4 drives damaging lipid accumulation via contact-dependent neuron-oligodendrocyte-microglia interaction in Alzheimer's disease
Min Joo Kim, Jessica R. Blumenfeld, … Yadong Huang·bioRxiv·Dec 9, 2025
- APOE4/4 is linked to damaging lipid droplets in Alzheimer's microglia
Michael Seamus Haney, Róbert Pálovics, … Tony Wyss‐Coray·bioRxiv·Jul 21, 2023
- Loss of neuronal lysosomal acid lipase drives amyloid pathology in Alzheimer's disease
Alexandra Barnett, Elizabeth M. McNair, … Leon G. Coleman·Alzheimer s & DementiaPeer-reviewed·Jul 1, 2025
- Altered metabolic function induced by amyloid-beta oligomers and PSEN1-mutations in iPSC-derived astrocytes.
Richard J. Elsworthy, Mattéa J. Finelli, … Eric James Hill·bioRxiv·Aug 23, 2023
- Mechanistic multiscale modelling of energy metabolism in human astrocytes indicates morphological effects in Alzheimer's Disease
Sofia Farina, Valérie Voorsluijs, … Alexander Skupin·bioRxiv·Jul 21, 2022